Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages. 2004

Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
Biotron Limited, LPO Box A315, Eggleston Rd., Australian National University, Canberra, ACT 2601, Australia. gewart@biotron.com.au

We report that the amiloride analogues 5-(N,N-hexamethylene)amiloride and 5-(N,N-dimethyl)amiloride inhibit, at micromolar concentrations, the replication of human immunodeficiency virus type 1 (HIV-1) in cultured human blood monocyte-derived macrophages. These compounds also inhibit the in vitro activities of the HIV-1 Vpu protein and might represent lead compounds for a new class of anti-HIV-1 drugs.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000584 Amiloride A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705) Amidal,Amiduret Trom,Amiloberag,Amiloride Hydrochloride,Amiloride Hydrochloride, Anhydrous,Kaluril,Midamor,Midoride,Modamide,Anhydrous Amiloride Hydrochloride,Hydrochloride, Amiloride,Hydrochloride, Anhydrous Amiloride,Trom, Amiduret
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
January 1991, Research in virology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
March 2004, Journal of virology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
February 1993, Journal of leukocyte biology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
October 1987, The Journal of experimental medicine,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
April 2003, Journal of virology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
January 1992, Pathobiology : journal of immunopathology, molecular and cellular biology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
June 2004, The Journal of general virology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
January 1991, The Journal of infectious diseases,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
October 2007, The Journal of general virology,
Gary D Ewart, and Najla Nasr, and Hassan Naif, and Graeme B Cox, and Anthony L Cunningham, and Peter W Gage
September 2008, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!